个人简介
徐永涛,中共党员,博士研究生,副教授,硕士研究生导师,河南省高校科技创新人才,jbo竞博官网登录“太行青年学者”,jbo竞博官网登录“青年教学标兵”,jbo竞博官网登录医学工程学院医学装备成果转化办公室主任,新乡市生物医学信息研究重点实验室主任,河南省神经信息分析与药物智能设计国际联合实验室常务副主任,中国医药教育协会智能医学专业委员会常务委员。2013年12月获得英国女王大学计算生物学与计算化学博士学位。主要从事医学信息研究方面的教学科研工作,研究方向为计算机辅助药物设计,人工智能在医学方面的应用。近年来个人共发表论文32篇,其中SCI论文26篇,中文核心6篇,参与学术著作2部。主持或参与国家自然科学基金青年科学基金项目4项,国家留学基金委项目1项。主持并完成省级项目3项。第二届全国智能技术应用大赛一等奖、中国医药教育协会科技创新奖二等奖。
联系方式:
jbo竞博官网登录北校区科技楼七楼733室
电话:0373-3831393
mail: yxu@xxmu.edu.cn;
研究方向:
计算机辅助药物设计:抗癌和抗病毒小分子创新药物研发
人工智能在医学上的应用:临床与生物医学大数据融合技术;临床辅助诊疗
招生方向:
学术学位硕士(学硕):生物医学工程
专业学位硕士(专硕):生物与医药、电子信息
教育经历:
2010/09-2013/12,英国女王大学,计算生物学与计算化学,博士
2009/09-2010/08,浙江大学,软件工程,硕士
2001/09-2006/07,北京科技大学,信息管理与信息系统,学士
承担项目:
1. 国家自然科学基金委员会,青年项目,21603180,计算设计以信封蛋白为靶点的抗登革热病毒肽抑制剂与初步实验验证,2017-01至2019-12,20万元,结项,主持
2. 国家自然科学基金委员会, 面上项目, 82273816,LSD1/MAO特异性激活的喜树碱类LSD1/TopoI双重抑制剂的设计合成、抗肿瘤活性评价及协同免疫治疗研究,2023-01至2026-12,52万元,在研,第一参与人
3. 国家自然科学基金委员会, 联合项目, U1704184,特异性靶向LSD1小分子降解剂的设计、合成及抗肿瘤活性研究,2018-01至2020-12,51万元,结项,第一参与人
4. 国家自然科学基金委员会,青年项目,21803049,黄酮醇-金纳米抗氧化剂生物界面性质和生物相容性的研究,2019-01至2021-12,26万元,结项,第二参与人
5. 国家留学基金委,地方合作项目,201708410492,计算设计螺旋蛋白为靶点的抗癌抑制剂研究,2018-09至2019-09,15万元,结项,主持
6. 河南省教育厅,河南省高校科技创新人才项目,22HASTIT050, 计算设计精准靶向主蛋白酶的抗新冠病毒小分子抑制剂及实验验证,2022-01至2024-12,30万元,在研,主持
7.河南省教育厅,河南省科技攻关项目,202102310875, 计算设计抗新冠病毒小分子药物及实验验证,2021-01至2022-12,在研,主持
6. 河南省人力资源和社会保障厅,2023年度留学人员科研择优资助项目,新型苯并呋喃核HCV NS5B聚合酶泛基因型抑制剂的计算设计与分子模拟研究,2023-01至2024-12,5万元,在研,主持
8. 河南省财政厅,河南省外专局项目,2014【131】,统计势能在评价蛋白稳定性的应用,2014-10至2015-01,5万元,结项,主持
近五年代表性论文
(1) Gao Q, Guo Y, Cao P, Fan G, Xu Y*. Regioselective synthesis of indazolo[2,3-a]quinazolines enabled by I2/S-facilitated annulation relay dehydrogenative aromatization of cyclohexanones. Chem Commun (Camb). 2023 Nov 21;59(93):13835-13838.SCI/二区top/6.1
(2) 贾梦珠,韩迪,路嘉瑞,高云龙,徐永涛*.基于丁酸钠的新型HDAC4抑制剂的设计与模拟[J].化学研究与应用,2023,35(07):1556-1564.中文核心期刊
(3) 畅豫霄,董亚东,徐永涛*.基于图卷积神经网络和拓扑特征的微核糖核酸-疾病关联预测模型[J].生物医学工程研究,2023,42(02):122-130.中文核心期刊
(4) Duan Y, Yu T, Jin L, Zhang S, Shi X, Zhang Y, Zhou N, Xu Y*, Lu W, Zhou H, Zhu H, Bai S, Hu K, Guan Y. Discovery of novel, potent, and orally bioavailable HDACs inhibitors with LSD1 inhibitory activity for the treatment of solid tumors.[J] .Eur J Med Chem, 2023, 254: 115367.SCI/一区/5.6
(5) Li T, Cui N, Fan J, Liu X , Guan J, Zhang W, Li Y, Gao Q, Liu Y, Xu Y, Wan L, Guo C, and Wang Y. Engineering βagarase Aga0917 from Pseudoalteromonas fuliginea YTW1-151 to Improve the Thermostability and Enzyme Activity: ACS Sustainable Chem. Eng. 2022, 10, 15437−15449.SCI/一区/8.1
(6) Xu Y, Fan B, Gao Y, Chen Y, Han D, Lu J, Liu T, Gao Q, John Zhang Z, Wang M. Design Two Novel Tetrahydroquinoline Derivatives against Anticancer Target LSD1 with 3D-QSAR Model and Molecular Simulation.Molecules. 2022 Nov 30;27(23):8358.SCI/二区/4.9
(7) Zhou X, Zhao F, Xu Y, Guan Y, Yu T, Zhang Y, Duan Y∗,Zhao Y∗. A comprehensive review of BET-targeting PROTACs for cancer therapy, Bioorganic & Medicinal Chemistry, 2022(73).SCI/三区/3.6
(8) Gao Q, Sun Z, Wu M, Guo Y, Han X, Yan J, Ha M,Le Q, Xu Y∗. Di-tert-butyl peroxide as an effective two-carbon unit in oxidative radical cyclization toward 7-methylazolo[1,5-a] pyrimidines, Org Chem Front,2022(04).SCI/一区/5.3
(9) Xu Y∗, Gao Y, Yang M, Wang M, Lu J, Wu Z, Zhao J, Yu Y, Wang C, Zhao Z, Gao Q, Duan Y∗, Han D∗. Design and identification of two novel resveratrol derivatives as potential LSD1 inhibitors. Future Med Chem, 2021, 13: 1415-1433.SCI/二区/3.8
(10) 陈依帆,赵俊强,杨敏,贺子豪,高云龙,刘鸿仪,徐永涛*.二苯乙烯类LSD1抑制剂的分子对接及分子动力学模拟研究[J].分子科学学报,2021,37(03):206-213.中文核心/中国科技核心期刊
(11) Zhao Z,Li J,Niu Y,Wang C, Zhao J, Yuan Q, Ren Q, Xu Y, Yu Y. Classification of Schizophrenia by Combination of Brain Effective and Functional Connectivity. Front Neurosci, 2021(15): 651439. SCI/二区/3.7
(12) Duan Y*, Jin L, Ren H, Zhang S, Liu Y, Xu Y, He Z, Song Y, Yuan H, Chen S, Guan Y*. Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer. European Journal of Medicinal Chemistry.2021 ( 220) 113453. SCI/一区/6.5
(13) Li X, Liu H, Wu X, Xu R, Ma X, Zhang C, Song Z, Peng Y, Ni T*, Xu Y∗. Exploring the interactions of naringenin and naringin with trypsin and pepsin: Experimental and computational modeling approaches. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2021(258 ) 119859. SCI/二区/4.1
(14) Yu J, Li X, Liu H, Peng Y, Wang X, Xu Y. Interaction behavior between five flavonoids and pepsin: Spectroscopic analysis and molecular docking. Journal of Molecular Structure,2020(1223),128978. SCI/三区/3.1
(15) 刘鸿仪,杨敏,陈依帆,贺子豪,张松杰,徐永涛*.Mtb_G5K同源建模及其与[3, 2-c]喹啉对接研究.化学研究与应用,2020, 32(7):1200-1206.中文核心/CA收录
(16) Gao Q, Wu M, Zhang K, Yang N, Liu M, Li J, Fang L, Bai S, Xu Y∗. I-2-Catalyzed Aerobic α,β-Dehydrogenation and Deamination of Tertiary Alkylamines: Highly Selective Synthesis of Polysubstituted Pyrimidines via Hidden Acyclic Enamines. Org Lett, 2020,22(14), 5645-5649. SCI/一区/6.5
(17) Zhao Z, Wang C, Yuan Q, Zhao J, Ren Q, Xu Y, Li J, Yu Y∗. Dynamic changes of brain networks during feedback-related processing of reinforcement learning in schizophrenia. Brain Research, 2020(1746), 146979.SCI/三区/3.2
(18) Wang C, Zhao Z, Ren Q, Xu Y, Yu Y∗.A novel multi-focus image fusion by combining simplified very deep convolutional networks and patch-based sequential reconstruction strategy. Applied Soft Computing Journal,2020, 91, 106253. SCI/二区/6.7
(19) Li X∗, Peng Y, Liu H, Xu Y, Wang X, Zhang C, Ma X. Comparative studies on the interaction of nine flavonoids with trypsin. Spectrochim Acta A Mol Biomol Spectrosc, 2020, 238, 118440. SCI/二区/4.1
(20) Xu Y*, He Z, Liu H, Chen Y, Gao Y, Zhang S, Wang M, Lu X, Wang C, Zhao Z, Liu Y, Zhao J, Yu Y, Yang M*. 3D-QSAR, molecular docking, and molecular dynamics simulation study of thieno[3,2-b]pyrrole-5-carboxamide derivatives as LSD1 inhibitors. RSC Adv, 2020, 10, 6927–6943. SCI/三区/3.3
(21) Xu Y*, He Z, Yang M, Gao Y, Jin L, Wang M, Zheng Y, Lu X, Zhang S,Wang C, Zhao Z,Zhao J, Gao Q*, Duan Y*. Investigating the Binding Mode of Reversible LSD1Inhibitors Derived from Stilbene Derivatives by 3D-QSAR, Molecular Docking, and Molecular Dynamics Simulation. Molecules, 2019, 24(24): 4479. SCI/三区/4.4
(22) 贺子豪,赵俊强,杨敏,张松杰,徐永涛*.使用遗传算法优化登革热病毒信封蛋白的肽抑制剂. 河南师范大学学报(自然科学版), 2019, 47(06):38-44. 中文核心
(23) Wang C , Zhao Z , Ren Q , Xu Y, Yu Y*. Dense U-net Based on Patch-Based Learning for Retinal Vessel Segmentation. Entropy, 2019, 21, 168. SCI/三区/2.5
(24) Lu X*, Zhang T, Wan R, Xu Y, Zhao C, Guo S. Numerical investigation of narrowband infrared absorber and sensor based on dielectric-metal metasurface, Optics Express, 2018, 26(8):10179. SCI/二区/3.9
(25) 赵俊强*,徐永涛,陈继超. 基于 Shearlet 变换结合动态融合的遥感图像融合算法.电子测量与仪器学报. 2018,32(11):35-42. CSCD
(26) Amir-Hassan A, Lee VS, Baharuddin A, Othman S, Xu Y, Huang M, Yusof R, Rahman NA, Othman R*. Conformational and energy evaluations of novel peptides binding to dengue virus envelope protein. Journal of Molecular Graphics & Modelling, 2017, 74:273-287. SCI/四区/2.5
(27) Yu L, Xu Y*, Wang F, Yang C, Liu G, Song X. Functional Roles of Pattern Recognition Receptors That Recognize Virus Nucleic Acids in Human Adipose-Derived Mesenchymal Stem Cells. Biomed Research International, 2016, 9872138. SCI/三区/3.4
(28) Mooney M ,Xu Y,Mcclory J,Huang M*. A disappearing act performed by magnesium: the nucleotide exchange mechanism of Ran GTPase by quantum mechanics/molecular mechanics studies. Theoretical Chemistry Accounts, 2016, 135(8). SCI/三区/1.8
(29) Xu Y, Yu S, Zou J , Huang M*. Identification of peptide inhibitors of enveloped viruses using support vector machine. PLoS One,2015 Dec 4;10(11):e0144171. SCI/三区/3.2
(30) Xu Y, Zho Xu, Huang M*. StaRProtein, A Web Server for Prediction of the Stability of Repeat Proteins. Plos One. 2015 Mar 25;10(3):e0119417. SCI/三区/3.2
(31) Aida B, Amir HA, Othman R, Xu Y, Huang M, Ario TB, Yusof R, Abdul RN, Othman S*. Dengue envelope domain III-peptide binding analysis via tryptophan fluorescence quenching assay. Chemical&pharmaceutical Bulletin, 2014,62(10), 947-955. SCI/四区/1.4
(32) Xu Y, Rahman N, Othman R, Hu P, Huang M*. Computational identification of self-inhibitory peptides from envelope proteins. Proteins, 2012, 80(9), 2154-68. SCI/三区/3.7